Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
General Physician
MBBS, MRCP (Medicine) UK, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, MRCGP ( INT ), M.C.P.S (Family Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Nephrologist
MBBS, Diplomat of American Board (Internal Medicine), Diplomat of American Board (Internal Medicine), Diplomat of American Board (Nephrology), FASN, FACP
Nephrologist
MBBS, Diplomat of American Board (Internal Medicine), Diplomat of American Board (Internal Medicine), Diplomat of American Board (Nephrology), FASN, FACP
Consultant Physician
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., M.D. (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures